Dr. Bertrand Tombal delivered a practical presentation titled “What Do You Need for Decision Making in mHSPC in 2026?”, focusing on how contemporary therapeutic choices in metastatic hormone-sensitive ...
A qualitative analysis explored how patients with hematopoietic malignancies seek meaning-making through relationships with family and friends at the end of life.
The bispecific T-cell engager talquetamab (Talvey) has some distinct adverse events (AEs) compared with drugs of the same class that target B-cell maturation antigen (BCMA) in mul ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results